Dehydro isradipine
CAS : 116169-18-7
Ref. 3D-FD20919
1mg | À demander | ||
2mg | À demander | ||
5mg | À demander | ||
10mg | À demander | ||
25mg | À demander |
Informations sur le produit
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester4-(4-Benzofurazanyl)-2,6-dimethyl -3,5-pyridinedicarboxylic acid methyl 1-methylethyl esterPN 203-831
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- 4-(4-Benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- Dehydro Isradipine
- Methyl Propan-2-Yl 4-(2,1,3-Benzoxadiazol-4-Yl)-2,6-Dimethylpyridine-3,5-Dicarboxylate
Dehydro isradipine is a high performance liquid chromatography (HPLC) method for the analysis of isradipine. It was developed as an alternative to the standard reversed-phase HPLC method. The HPLC method has been validated and found to be superior in terms of sensitivity, linearity, and capability for quantification. Dehydro isradipine can be analyzed by reversed-phase or liquid chromatography methods. Dehydro isradipine inhibits cytochrome P450 enzymes, which are involved in the metabolism of many drugs, thus affecting their efficacy. This inhibition may lead to adverse drug reactions or reduced therapeutic effect.
Propriétés chimiques
Question d’ordre technique sur : 3D-FD20919 Dehydro isradipine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages